For many people with type 2 diabetes and obesity, weight loss surgery does more than help them lose weight. Blood sugar often improves within days or weeks, and many patients need fewer diabetes medications afterward. Some go into remission, with normal blood sugar levels without medication. This guide explains why, what the research shows and who may benefit.
How surgery affects blood sugar
Weight loss itself improves how the body responds to insulin. But blood sugar often gets better soon after surgery, before much weight has been lost. That happens because surgery changes the hormones your gut releases after you eat, which help control blood sugar and appetite.
The effect is usually strongest after gastric bypass, which routes food past the first part of the small intestine. A gastric sleeve also improves blood sugar for many patients.
What the research shows
- Surgery vs. medication: in the STAMPEDE trial, people with type 2 diabetes were treated with intensive medical therapy alone or with surgery plus medical therapy. After 5 years, an HbA1c of 6.0% or lower was reached by 29% of gastric bypass patients and 23% of sleeve patients, compared with 5% of patients on medical therapy alone.
- Fewer medications: surgery patients in the same trial needed fewer diabetes medications, including insulin, than patients on medical therapy.
- Long-term results: a trial that followed patients for 10 years found that surgery patients were far more likely to remain in remission than patients treated with medication and lifestyle changes alone.
Based on this evidence, international diabetes organizations now include metabolic surgery as a treatment option for type 2 diabetes in people with obesity.
Remission is not a cure
Diabetes can return years later, especially if weight is regained, so regular checkups remain important. The chances of remission are usually better when:
- You have had diabetes for fewer years.
- You do not yet need insulin, or need only a small amount.
- You keep up with diet, activity and follow-up visits after surgery.
Who qualifies?
The 2022 guidelines from the American Society for Metabolic and Bariatric Surgery (ASMBS) recommend surgery for people with a BMI of 35 or more, and say it should be considered for people with type 2 diabetes and a BMI of 30 to 34.9. Insurance plans set their own criteria, often a BMI of 40 or more, or 35 or more with a condition such as diabetes. Our self-pay gastric sleeve is available from a BMI of 30.
Sleeve or bypass for diabetes?
Both operations help. Gastric bypass is often recommended when diabetes is a major concern or hard to control, and for people who also have significant acid reflux. A sleeve is a simpler operation that also improves blood sugar for many patients. Read more in Gastric Sleeve vs. Gastric Bypass.
Your diabetes medications after surgery
Because blood sugar can fall quickly after surgery, your diabetes medications are often reduced or stopped around the time of your operation. Our discharge instructions ask patients on diabetes medication to check their blood sugar before each dose. Never change your medications on your own. Dr. Wadiwala and the doctor who manages your diabetes will adjust them with you.
Talk to us about your options
If you have type 2 diabetes and are wondering whether surgery could help, your initial consultation is free. Dr. Wadiwala will review your health history, medications and goals with you. Call 281-653-6544 or request a consultation.
Related reading
- Gastric Sleeve vs. Gastric Bypass
- GLP-1 Medication vs. Weight Loss Surgery
- GLP-1 Medication vs. Surgery: Which Costs Less?
- Does Insurance Cover Weight Loss Surgery in Texas?
- How to Prepare for Weight Loss Surgery
- Life After Bariatric Surgery: The First 12 Months
- Diet After Bariatric Surgery: What You Need to Know
- Am I a Candidate for Weight Loss Surgery?
Sources
- Schauer PR, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes: 5-Year Outcomes (STAMPEDE). N Engl J Med. 2017;376:641-651.
- Mingrone G, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397:293-304.
- Rubino F, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016;39(6):861-877.
- Eisenberg D, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(12):1345-1356.
- Houston Surgical Weight Loss Discharge Instructions page.
This article is general information, not medical advice. Talk with your doctor about what is right for you.